Use of Nonprescription Weight Loss Products
Open Access
- 22 August 2001
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 286 (8) , 930-935
- https://doi.org/10.1001/jama.286.8.930
Abstract
Successful weight loss and healthy weight management depend on long-term lifestyle changes such as reducing calorie consumption and increasing physical activity. However, because these changes are difficult, easily obtained nonprescription weight loss products and prescription diet pills are an appealing alternative to the increasingly overweight US population. It has been speculated that individuals may use nonprescription products and prescription pills in place of lifestyle changes.1 No population-based studies have examined the relationship between use of overall nonprescription weight loss products and use of prescription weight loss pills or lifestyle changes for weight loss. Usage patterns of specific nonprescription products (eg, phenylpropanolamine [PPA] and ephedra) are also of particular interest because of safety concerns.Keywords
This publication has 12 references indexed in Scilit:
- Comment: Regulatory Environment for Dietary Supplements and Botanicals Targeted to Weight LossCritical Reviews in Food Science and Nutrition, 2001
- Alternative Treatments for Weight Loss: A Critical ReviewCritical Reviews in Food Science and Nutrition, 2001
- Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra AlkaloidsNew England Journal of Medicine, 2000
- Phenylpropanolamine and the Risk of Hemorrhagic StrokeNew England Journal of Medicine, 2000
- Content versus label claims in ephedra-containing dietary supplementsAmerican Journal of Health-System Pharmacy, 2000
- Double‐Blind, Randomized, Placebo‐Controlled Clinical Trials with Non‐Prescription Medications for the Treatment of ObesityObesity Research, 1999
- Trends in Alternative Medicine Use in the United States, 1990-1997JAMA, 1998
- Thermogenic synergism between ephedrine and caffeine in healthy volunteers: A double-blind, placebo-controlled studyMetabolism, 1991
- Beta-Adrenergic Receptors in Pathophysiologic States and in Clinical MedicinePublished by Springer Nature ,1991
- Adverse drug effects attributed to phenylpropanolamine: A review of 142 case reportsThe American Journal of Medicine, 1990